EUVIMEDEUVIMED entdecken
Crossref

Integrated clinical and transcriptomic analysis reveals miRNA-mediated mechanisms linking hearing loss to cognitive decline in Alzheimer's disease

Xin Wang iD, Bohan Zhang, Huixuan Ma, Aidi Shan, Qingjie Lian, Xiaodong Han, Chang Xu, Qi Yao, Boye Wen, Heya Luan, Shaoqi Li, Tong Cui iD und 5 weitere

Journal of Alzheimer’s Disease · 01.11.2026

DOI: 10.1177/13872877261501149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 01.11.2026. Verfasst von Xin Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Cen…. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, STI2030-Major Projects, Xicheng District Science and Technology Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hearing loss (HL) is a potent, modifiable risk factor for Alzheimer's disease (AD), but the underlying molecular mechanisms remain elusive. microRNAs (miRNAs) are potential key mediators given their roles in both neurodegeneration and auditory function.

Objective

To investigate whether peripheral blood miRNA profiles differ between AD patients with and without HL, and whether hsa-miR-6875-5p serves as a candidate molecular link.

Methods

In a case-control study of 41 AD patients (AD-HL n = 24, AD-non-HL n = 17), we performed neuropsychological assessments, plasma miRNA sequencing, target gene prediction, and external validation using public transcriptomic datasets.

Results

AD-HL patients showed significantly worse Montreal Cognitive Assessment and Auditory Verbal Learning Test delayed recall scores (p < 0.05). We identified 9 differentially expressed miRNAs, with hsa-miR-6875-5p being the most upregulated (3.29-fold, p = 0.041). Its predicted targets were enriched in synaptic plasticity-related pathways. External validation in AD brain datasets supported consistent upregulation of hsa-miR-6875-5p and downregulation of SYN1/PSD95. Validation in mouse cochlear datasets showed concordant expression trends for homologous miRNA and target genes. The absence of healthy control groups precludes determination of whether this miRNA signature is specific to AD-HL or a general feature of HL or AD.

Conclusions

This preliminary study identifies hsa-miR-6875-5p as a potential circulating biomarker linking HL to cognitive decline in AD. These findings are hypothesis-generating and require confirmation in larger cohorts, including healthy controls, and functional experiments.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkerhearing losshsa-miR-6875-5pmiRNAsynaptic plasticity

Autor:innen und Institutionen

  • Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China.
  • Department of Infectious Disease, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Zhejiang, China.
  • School of Biological Science and Medical Engineering, Beihang University, Beijing, China.
  • College of Integrated Traditional Chinese and Western Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Clinical Research Center, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China.

ORCID-Profile: Xin Wang, Tong Cui, Cuibai Wei

Förderung

  • National Natural Science Foundation of China
  • STI2030-Major Projects
  • Xicheng District Science and Technology Special Project
  • Shandong Medical and Health Science and Technology Project
  • Haiyou Health High-Caliber Talent Project

Zitieren

APA

Wang, X., Zhang, B., Ma, H., Shan, A., Lian, Q., Han, X., Xu, C., Yao, Q., Wen, B., Luan, H., Li, S., Cui, T., Lv, S., Sun, Q., Guo, J., Chen, R., & Wei, C. (2026). Integrated clinical and transcriptomic analysis reveals miRNA-mediated mechanisms linking hearing loss to cognitive decline in Alzheimer's disease. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261501149

Vancouver

Wang X, Zhang B, Ma H, Shan A, Lian Q, Han X, et al. Integrated clinical and transcriptomic analysis reveals miRNA-mediated mechanisms linking hearing loss to cognitive decline in Alzheimer's disease. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261501149

BibTeX
@article{Wang2026,
  author = {Wang, Xin and Zhang, Bohan and Ma, Huixuan and Shan, Aidi and Lian, Qingjie and Han, Xiaodong and Xu, Chang and Yao, Qi and Wen, Boye and Luan, Heya and Li, Shaoqi and Cui, Tong and Lv, Sirong and Sun, Qingyuan and Guo, Jinxuan and Chen, Runqi and Wei, Cuibai},
  title = {Integrated clinical and transcriptomic analysis reveals miRNA-mediated mechanisms linking hearing loss to cognitive decline in Alzheimer's disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261501149}
}
Kostenlos starten →